Form 8-K - Current report:
SEC Accession No. 0001104659-25-117387
Filing Date
2025-12-01
Accepted
2025-12-01 17:17:48
Documents
15
Period of Report
2025-12-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2532031d2_8k.htm   iXBRL 8-K 31103
2 EXHIBIT 1.1 tm2532031d2_ex1-1.htm EX-1.1 245873
3 EXHIBIT 5.1 tm2532031d2_ex5-1.htm EX-5.1 8479
7 GRAPHIC tm2532031d2_ex5-1img001.jpg GRAPHIC 7698
  Complete submission text file 0001104659-25-117387.txt   526758

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA armp-20251201.xsd EX-101.SCH 3026
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20251201_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20251201_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2532031d2_8k_htm.xml XML 3547
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 251540726
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)